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OBJECTIVES: The goals of the study were the following: 1) to determine the frequency of psychiatric disorders and
irritable bowel syndrome in patients with asthma and 2) to compare the frequency of these disorders in patients
with asthma to their frequency in healthy controls.
INTRODUCTION: Patients with asthma have a higher frequency of irritable bowel syndrome and psychiatric
disorders.
METHODS: We evaluated 101 patients with bronchial asthma and 67 healthy subjects. All subjects completed the
brief version of the Bowel Symptoms Questionnaire and a structured clinical interview for DSM-IV axis disorders
(SCID-I/CV).
RESULTS: There were 37 cases of irritable bowel syndrome in the group of 101 stable asthma patients (36.6%) and
12 cases in the group of 67 healthy subjects (17.9%) (p=0.009). Irritable bowel syndrome comorbidity was not
related to the severity of asthma (p=0.15). Regardless of the presence of irritable bowel syndrome, psychiatric
disorders in asthma patients (52/97; 53.6%) were more common than in the control group (22/63, 34.9%) (p=0.02).
Although psychiatric disorders were more common in asthma patients with irritable bowel syndrome (21/35, 60%)
than in those without irritable bowel syndrome (31/62, 50%), the difference was not significant (p=0.34). In asthma
patients with irritable bowel syndrome and psychiatric disorders, the percentage of forced expiratory volume in 1 s
(FEV1) was lower than it was in those with no comorbidities (p=0.02).
CONCLUSIONS: Both irritable bowel syndrome and psychiatric disorders were more common in asthma patients
than in healthy controls. Psychiatric disorders were more common in asthma patients with irritable bowel syndrome
than in those without irritable bowel syndrome, although the differences failed to reach statistical significance. In
asthma patients with IBS and psychiatric disorders, FEV1s were significantly lower than in other asthma patients. It is
important for clinicians to accurately recognize that these comorbid conditions are associated with additive
functional impairment.
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INTRODUCTION
Asthma is a serious public health problem worldwide,
with an estimated 300 million affected individuals. Asthma
is a chronic inflammatory disorder of the airways with
symptoms that include recurring episodes of wheezing,
breathlessness and cough. When uncontrolled, asthma can
impose severe limits on daily life, and it is sometimes fatal.
The frequency of asthma is increasing in most countries. It
appears that the global frequency of asthma ranges between
1% and 18% of the population in different countries.
1
Reported comorbidities include gastrointestinal distur-
bances.
2
Irritable bowel syndrome (IBS) is a chronic functional
gastrointestinal (GI) disorder that affects 10–15% of the
population and has a higher frequency in women and a
variable frequency in different populations.
3 As outlined by
the Rome II criteria, IBS is defined as persistent pain or
discomfort that is associated with two of the following three
criteria: symptomatic relief with defecation, looser stools
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591with more frequent bowel movements or harder stools with
rarer bowel movements. The Rome II criteria require the
presence of these symptoms for 12 weeks of the previous 12
months for establishment of a diagnosis.
4 In patients with
IBS, bowel habits are altered (constipation and/or diarrhea)
with the absence of any apparent mechanical, biochemical
or inflammatory changes in the gastrointestinal tract.
The relationship between bronchopulmonary disorders
and IBS was first suspected in 1991 when White et al.
demonstrated a higher frequency of bronchial hyperrespon-
siveness in patients with IBS.
5 Later, several studies
reported an association between IBS and asthma.
6-8
Curiously, psychiatric disorders, particularly depressive
and anxiety disorders, have been shown to be significantly
more prevalent in asthma patients than in the general
population.
9-11
Diseases of the digestive tract frequently coexist with
psychological disorders. Among referred patients with IBS,
psychiatric disorders have also been reported to be very
common, leading to the argument that IBS is a part of the
psychiatric disease spectrum and not a unique condition.
12
To our knowledge, no studies investigating the presence
of psychiatric diagnoses in asthma patients with and
without IBS have been cited in the previous literature.
The current study’s goals were as follows: 1) to determine
the frequency of IBS, 2) to reveal the frequency of
psychiatric disorders using a structured clinical interview
for DSM-IV axis disorders (SCID-I/CV) in asthma patients,
and 3) to compare these frequencies in asthma patients to
those in controls without asthma.
MATERIALS AND METHODS
Study Design
We evaluated 101 consecutive patients with stable
bronchial asthma as defined by the Global Initiative for
Asthma (GINA) guidelines (1) and 67 healthy subjects who
were referred to the Gaziosmanpasa University Medical
Faculty Research and Training Hospital between June 2006
and December 2009. This was a sectional, descriptive study.
The demographic features (age, gender, smoking status,
education, occupation), disease durations, respiratory
symptoms and clinical examination findings were recorded.
Pulmonary function tests were performed for each subject
by the same technician using the Jaeger Master Screen
Pneumo device. Asthma patients were separated into two
groups in this study. Group 1 included asthma patients with
IBS, and group 2 included asthma patients without IBS. The
frequencies of IBS and psychiatric disorders were deter-
mined for all asthma patients, in subgroups of asthma
patients and in control subjects.
The following patients and control subjects were excluded
from the study: those with acute respiratory system infec-
tions, organic GI disease, a history of abdominal surgery, a
pulmonarydisease other than asthma,cardiovascular disease
or any other systemic diseases such as diabetes mellitus,
thyroid and renal disorders, chronic inflammatory diseases
such as rheumatoid arthritis and scleroderma, or uncon-
trolled hypertension. Pregnant and puerperal women,
patients using drugs affecting smooth muscle and the
autonomic nervous system, and patients experiencing acute
asthma attacks were also excluded. Other exclusion criteria
were the current use of any medications for a psychiatric
disorderand thepresenceofanyorganicdisordersthatmight
affect the psychiatric assessment. To prevent any bias and
sideeffectsof medications, we excluded asthma patients who
were hospitalized or discharged from the hospital in the last
year. No patients received IV, nebulized, or oral b2-agonists,
IV aminophylline, oral/parenteral corticosteroids, or immu-
nosuppressive therapy during the study or in the six months
leading up to it. Patients also had to be exacerbation-free
during this period. Control healthy subjects were recruited
from the hospital or university staff. They had no history of
asthma and no respiratory complaints. Four of the asthma
patientsandtwohealthycontrolsubjects were excludedfrom
the study. Current usage of psychiatric medicine might affect
and make psychiatric assessment difficult, so we excluded
people taking psychiatric medicine from the study. Only
patients who answered all questions were included.
Written informed consent was obtained from the subjects
after they were told about the design, aim and details of
the cross-sectional study. The study conformed to the
Declaration of Helsinki.
The assessment of asthma and its severity
Diagnosis of asthma was based on clinical history, the
forced expiratory volume in first second FEV1, or peak
expiratory flow .15% and diurnal variations of peak
expiratory flow rate .20% according to GINA (The Global
Initiative for Asthma) criteria.
1 Pulmonary function tests
were performed using a calibrated flow sensor spirometer
(Model D-97204 Jaeger Toennies; Type. APS-Pro;
Hoechberg, Germany) according to the European
Respiratory Society Standardization.
13 The best of three
reproducible loops was selected for the study. The principal
endpoint was the estimated value of FEV1. In addition, the
forced vital capacity (FVC) and the ratio of FEV1/FVC were
recorded. According to the spirometry results, clinical
asthma symptomatology and usage of medications, espe-
cially inhaled corticosteroids, asthma patients were classi-
fied into 4 groups for their asthma severity according to
GINA: mild intermittent, mild persistent, moderate persis-
tent and severe persistent.
The assessment of IBS
The brief version of the Bowel Symptoms Questionnaire
(BSQ) was used to assess the Rome II criteria and general GI
symptomatology.
14 In particular, the first four questions of
the BSQ were used to assess the symptoms that were
consistent with a diagnosis of IBS. These questions included
(1) ‘‘In the past three months, have you had continuous or
repeated discomfort or pain in your lower abdomen (If you
are female, this should not be related to your menstrual
cycle or period)?’’ (1a) ‘‘Is this discomfort or pain typically
relieved by a bowel movement?’’ (1b) ‘‘Is this discomfort or
pain typically associated with a change in the frequency of
bowel movements (i.e., having more or fewer bowel
movements a day)?’’ (1c) ‘‘Is this discomfort typically
associated with a change in the consistency of the stool
(i.e., softer or harder)?’’ An additional question was
incorporated in to the BSQ to better assess the Rome-II
criteria, which included the Rome-II time course criteria,
that is, symptoms in at least 12 weeks of the previous 12
months. The BSQ is a previously validated, self-report
instrument used to measure gastrointestinal symptoms.
Diagnosis of IBS was based on Rome II criteria.
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Asthma patients and control subjects were evaluated for
psychiatric diagnoses in the psychiatry department using a
semi-structured sociodemographic information form and
they were evaluated for DSM-IV axis I disorders using a
structured clinical interview (SCID-I/CV)
15 in the Turkish
version.
16
Statistical Analyses
For statistical comparisons of qualitative parameters, chi-
square and Fisher’s exact tests were used. For measurable
categorical variables, tests for significant differences between
two means and one-way analyses of variance (ANOVAs)
were utilized. P,0.05 was considered significant.
RESULTS
One hundred and one subjects with stable, bronchial
asthma (77 women, 24 men) and 67 healthy subjects (49
women and 18 men) were included in the study. The mean
ages were 42.87¡11.73 yrs and 40.47¡11.25 yrs for the
asthma and control groups, respectively (p=0.19, t: 1.29).
The demographic and clinical features of the asthma
patients and the control subjects with and without IBS are
shown in Table 1.
There were 37 IBS cases among 101 patients with stable
bronchial asthma (36.6%) and 12 IBS patients among 67
healthy subjects (17.9%). The frequency of IBS was
significantly higher in asthma patients than in healthy
individuals (36.6% and 17.9%, respectively; p=0.009)
(Table 2). For all subjects studied, the frequency of IBS
was not significantly different between females and males
(p=0.38) (Table 3). IBS comorbidity was not correlated with
age, gender, occupation, level of education, smoking status,
or severity of asthma (respectively, p=0.39, p=0.38,
p=0.55, p=0.56, p=0.66, p=0.15) (Table 4). The frequency
of IBS comorbidity was not significantly different when
considering FEV1 and FEV1/FVC ratios. When Group 1 and
Group 2 were compared, the differences between the means
were not significant (FEV1: 89.88¡17.29, and 95.87¡13.75,
t:1.90, p=0.06; FEV1/FVC: 77.97¡10.48, and 77.46¡7.29,
t:-.28, p=0.77, respectively) (Table 5).
Regardless of the presence of IBS, psychiatric disorders
were more common in asthma patients than in the control
subjects (52/97, 53.6%, and 22/63, 34.9%, respectively;
p=0.02) (Table 2). Psychiatric diagnoses made in the patient
Table 1 - Sociodemographic data.
Asthma patients (n=98) Control subjects (n=65) X
2 pt
Age (yrs) 42.87¡11.73 40.47¡11.25 0.19 1.29
Sex
female 75 (76.5%) 48 (73.8%) 0.152 0.697
male 23 (23.5%) 17 (26.2%)
Education
illiterate 1 (1%) 1 (1.5%) 37.82 0.0001
literate 3 (3%) 3 (4.6%)
primary education 63 (65.6%) 11 (16.9%)
high school 11 (11.5%) 16 (24.6%)
higher education 18 (18.8%) 34 (52.3%)
Occupation
retired 9 (9.2%) 4 (6.2%) 21.83 0.003
housewife 55 (56.1%) 22 (33.8%)
worker 6 (6.1%) 10 (15.4%)
employee 15 (15.3%) 24 (36.9%)
out of work 2 (2.0%) 1 (1.5%)
student 3 (3.1%) -
free 3 (3.1%) 4 (6.2%)
farmer 5 (5.1%) -
Smoking history
nonsmoker 74 (75.5%) 41 (63.1%) 3.70 0.15
ex-smoker 12 (12.2%) 9 (13.8%)
current smoker 12 (12.2%) 15 (23.1%)
Severity of Asthma --
Intermittent asthma 2 (2%)
Persistent asthma
mild 63 (62.4%)
moderate 31 (30.7%)
severe 5 (5%)
p,0.05: significant.
Table 2 - The frequency of IBS and psychiatric disorders in asthma patients and control subjects.
Asthma patients (n=101) Control subjects (n=67) x
2 p
IBS comorbidity 37 (36.6%) 12 (17.9%) 6.835 0.009*
Asthma patients (n=97 ) Control subjects (n=63 )
Psychiatric disorders 52 (53.6%) 22 (34.9%) 5.36 0.02*
IBS: irritable bowel syndrome.
*p,0.05=significant.
CLINICS 2011;66(4):591-597 Role of psychiatric disorders in asthma patients
Yilmaz A et al.
593group and the control group and the intergroup compar-
isons of diagnoses are shown in Table 6. Although
psychiatric disorders were more common in Group 1 (21/
35, 60%) than in Group 2 (31/62, 50%), the difference was
not statistically significant (p=0.34) (Table 7). Twenty
asthma patients had IBS comorbidities together with
psychiatric disorders, while 31 asthma patients did not.
There was a statistically significant difference between the
two patient groups with respect to the forced expiratory
volume in 1 s (t: 2.41, p=0.02). There was no statistical
difference between the two patient groups in terms of the
ratio of the FEV1/FVC (t: 0.14, p=0.8).
The comorbidities of psychiatric disorders were not
related to age, gender, occupation, educational status,
smoking history, or duration or severity of asthma
(p=0.89, p=0.20, p=0.61, p=0.59, p=0.43, p=0.54, and
p=0.07, respectively) (Table 4 and 8). There were no
differences for the FEV1 or FEV1/FVC ratio in asthma
patients with and without psychiatric disorders (FEV1:
91.31¡15.80, and 96.35¡14.89, p=0.11; FEV1/FVC:
77.23¡9.26, and 78.35¡7.92, p=0.52, respectively) (Table 5).
DISCUSSION
To our knowledge, this study is the first to investigate
different psychiatric diagnoses in asthma patients with and
without IBS. It is important for clinicians to accurately
recognize the linkage between psychiatric diagnoses,
asthma and IBS because these comorbid conditions are
associated with increased asthma symptom burden and
additive functional impairment.
17
Kennedy et al.
18 showed that IBS, gastroesophageal reflux
symptoms, and symptomatic bronchial hyperreactivity
occurred more frequently than expected and that the
conditions were independently associated with each other.
Symptoms of patients with diagnoses of asthma and IBS
overlap considerably. These associations are difficult to
explain. One possible explanation is that the gastrointestinal
and respiratory symptoms in our subjects are caused by a
common (but as yet unidentified) underlying disorder
capable of producing symptoms in more than one physio-
logical system and resulting in an indirect association
between seemingly disparate conditions. A number of
candidate mechanisms accounting for this association exist.
A generalized disorder involving bronchial, gastrointestinal,
and smooth muscles might be implicated in this association.
A more complex neuromuscular disorder with altered
visceral sensitivity and shared transmitter dysfunction is
another possible suggestion. Another possibility is the
presence of an underlying inflammatory etiology leading
to respiratory and gastrointestinal symptoms. In IBS,
evidence related to colonic inflammation comprising
infiltrates of lymphocytes and mast cells has been
documented.
19,20 A correlation was found between markers
of inflammation and major depressive disorder.
21 Increased
fibrinogen, myeloperoxidase and ferritin and decreased
transferrin serum levels have been found to be related to
major depressive disorder.
21
Huerta and et al.
7 found that there was a slightly
increased risk of IBS in asthma patients compared with
the general population and that the risk of IBS was reduced
by the use of oral steroids in asthma patients. In our study,
the patients had not used oral steroids in the last 6 months.
Yazar et al.
8 studied 133 patients with IBS and showed that
15.8% of them had bronchial asthma according to history,
clinical, and pulmoner function test findings. There were 45
(33.8%) and 8 (5.8%) subjects with respiratory symptoms in
the IBS and control groups, respectively (p,0.0001).
8 In
another study conducted in patients 60 years of age (aged
45.1¡14.9 years), Roussos et al.
6 reported that the pre-
valence of IBS was significantly higher in asthmatics (62/
150, 41.3%) than in subjects with other pulmonary disorders
(29/130, 22.3%) and in age-matched healthy controls (25/
120, 20.8%, p,0.001). Similarly, the frequency of IBS in
asthma patients and healthy controls was 36.6% and 17.9%,
respectively, in our study. Ekici et al.
22 showed that the
prevalence of IBS in the stable asthmatic group ((n=65
young (age ,60 years) and 66 elderly (age.or=60 years))
was higher than that in the control group (119 age-matched
healthy volunteers (27.5% versus 16.8%, p=0.04). The
prevalence of IBS was significantly higher in young
asthmatics than in age-matched healthy controls (36.9%
versus 20.3%, p=0.04) and elderly asthmatics (36.9% versus
18.2%, p=0.01).
22 In our study, the frequency of IBS was
similar to that observed in the previous studies, and the
asthma patients’ mean age was 42. Epidemiological studies
suggest that the frequency of IBS declines with age, and
symptoms of IBS might change and disappear in the elderly
population as time passes, possibly because of alterations in
the perception of pain. However, very little research into the
risk factors, diagnosis and treatment of IBS in the elderly has
been performed.
23 Ekici et al. applied logistic regression
analysis to identify younger age (odds ratio, 2.1 [1.1-3.8];
p=0.01) as an independent risk factor for IBS.
22 In our
Table 3 - The distribution of IBS comorbidity and
psychiatric disorders according to gender.
Female Male x
2 p
n=77 n=24 0.75 0.38
IBS comorbidity 30 7
n=74 n=23 1.63 0.20
Psychiatric disorders 37 (50%) 15 (65.2%)
IBS: irritable bowel syndrome.
Table 4 - Statistical data of the distribution of IBS
comorbidity and psychiatric disorders according to
sociodemographic data, clinical data and respiratory
function tests for asthma patients.
IBS comorbidity Psychiatric disorders
x
2 ptx
2 pt
Age 0.39 0.85 0.89 0.13
Gender 0.75 0.38 1.63 0.20
Education 2.93 0.56 2.75 0.59
Occupation 5.85 0.55 5.38 0.61
Smoking history 0.66 0.43 0.43 0.77
Duration
of asthma
0.10 1.63 0.54 0.61
FEV1 0.06 1.90 0.11 1.60
FEV1/FVC 0.77 0.28 0.52 0.63
Severity
of asthma
5.31 0.15 6.79 0.07
FEV1: Forced expiratory volume in one second.
FEV1/FVC: Ratio of forced expiratory volume in 1 s-to-forced vital capacity
both expressed in percentages.
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patient age.
Ozol et al.
23 found that although the rate of IBS was
higher in moderate and severe persistent asthma patients
than in mild persistent asthma patients, the difference was
not significant. In our study, the rate of IBS was similar for
all groups. Roussos et al. showed a lack of statistically
significant difference in spirometric values between
asthmatic patients with IBS (FEV1/FVC: 64.9 ¡ 11.6)
and those without IBS (FEV1/FVC: 65.7 ¡ 12.2, p.0.05).
6
Likewise, Ekici et al.
22 found no statistically significant
difference in spirometric values between asthma patients
with IBS and those without IBS (FEV1/FVC: 82.3¡9.6
versus 80.9¡10.1, respectively, p.0.05). McCauley et al.
17
reported a similar degree of additive impairment based on
having one and more anxiety or depressive disorders at
each level of asthma severity. This finding suggests that
this effect is not due to greater severity of asthma in youth
with psychiatric disorders. In our study, we did not detect
differences in the rates of comorbidities of psychiatric
disorders and IBS for different levels of asthma severity in
adult asthma patients, which is similar to the findings of
the above-mentioned studies.
Some researchers have found correlations between
depressive symptoms and decreased forced expiratory
volume in 1 second (FEV1) and FVC,
25 while other
researchers have found no correlation between depressive
symptoms and FEV1 or bronchial hyperresponsiveness to a
methacholine challenge.
26 It is possible that the stress
related to anxiety and depressive disorders might trigger
airway obstruction through physiologic mechanisms, result-
ing in more symptoms.
27 In our study, we also observed that
the comorbidities of psychiatric disorders did not change as
the severity of asthma state worsened. All of our patients’
asthma was stable and they had not had asthma exacerba-
tions in the past year.
Roussos et al.
6 showed that the prevalence of IBS is
significantly higher in females (78/214, 36.4%) than in
Table 5 - The distribution of IBS comorbidity and psychiatric disorders according to FEV1, FEV1/FVC parameters.
Group 1 Group 2 p t
FEV1 89.88¡17.29 95.87¡13.75 0.06 1.90
FEV1/FVC Group 1 Group 2 0.77 0.28
77.97¡10.48 77.46¡0.91
FEV1 Asthma patients with
psychiatric disorders
Asthma patients without psychiatric
disorders
0.11 1.60
91.31¡15.80 96.35¡14.89
FEV1/FVC Asthma patients with
psychiatric disorders
Asthma patients without psychiatric
disorders
0.52 0.63
77.23¡9.26 78.35¡7.92
FEV1 Asthma patients with IBS
and psychiatric disorders
Asthma patients without IBS and psychiatric
disorders
0.02* 2.41
86.25¡17.35 96.87¡13.96
FEV1/FVC Asthma patients with IBS
and psychiatric disorders
Asthma patients without IBS and psychiatric
disorders
0.88 0.14
78.45¡12.06 78.83¡7.52
FEV1: Forced expiratory volume in one second, FVC: Forced vital capacity.
FEV1/FVC: Ratio of forced expiratory volume in 1 s to forced vital capacity, both expressed in percentages.
Group 1: Asthma patients with IBS.
Group 2: Asthma patients without IBS.
IBS: Irritable bowel syndrome.
All values are presented as the mean ¡ SD.
*p,0.05=significant.
Table 6 - The distribution of DSM-IV-TR diagnostic categories among Group 1 and Group 2 patients and control subjects.
Group 1 Group 2 All asthma patients Control subjects
n=35 n=62 n=99 n=65
Depressive disorder 9 (42.9%) 17 (54.8%) 26 (50.0%) 10 (45.5%)
Anxiety disorder 5 (23.8%) 5 (16.1%) 10 (19.2%) 1 (4.5%)
Nicotine dependence - 4 (12.9%) 4 (7.7%) 8 (36.4%)
Depersonalization disorder - - - -
Adjustment disorder 4 ( 19%) 4 (12.9%) 8 (15.4%) 3 (13.6%)
Somatoform disorder 3 (14.3%) - 3 (5.8%) -
Primary insomnia - 1 (3.2%) 1 (1.9%) -
All psychiatric disorders 21 31 52 22
Results x
2=0.90 p=0.34 x
2=11.86 p=0.03*
Group 1: Asthma patients with IBS.
Group 2: Asthma patients without IBS.
IBS: Irritable bowel syndrome.
*p,0.05=significant.
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control subjects. Similarly, Yazar and Celebi et al. found
that IBS is more common in females than in males.
8,28 No
associations between IBS and gender were found in our
study.
The frequency of IBS was highest (10.2%) in persons who
were illiterate and lowest (3.0%) in university graduates. IBS
was more prevalent in individuals with low educational and
economic status.
28 In our study, we could not find any
correlation between IBS and the educational level of the
patients.
A recent epidemiologic study performed in children and
adolescents 9 to 17 years of age reported that young people
with a history of asthma were more likely to have an anxiety
disorder, simple phobia, separation anxiety or an over-
anxious disorder compared with controls.
29 In another
study with 1,000 adult respondents, severe lifetime asthma
was associated with an increased likelihood of panic
disorder, social phobia, generalized and other types of
anxiety, and bipolar disorder.
11 Katon et al.
30 suggested that
there is an increased incidence in all types of anxiety and
depressive disorders in youths with asthma (16.3%, all age
11-17 with asthma, n=781) compared with controls (8.6%,
n=598). Youths with asthma have an almost two-fold
higher prevalence of comorbid DSM-IV anxiety and
depressive disorders compared with control youths. Those
with $1 anxiety or depressive disorders were significantly
more likely to be female, to have parents with less
education, to have more medical comorbidities, to have a
more recent diagnosis of asthma, and to be smoking.
30 In
contrast to Katon et al., we did not find any association
between psychiatric disorders and gender, education level,
duration of asthma or smoking history. Additionally, we
excluded asthma patients with medical comorbidities from
our study. Furthermore, symptoms of anxiety (i.e., shortness
of breath, tachycardia) and depressive disorders (i.e.,
insomnia, fatigue) may overlap with symptoms of asthma.
Lavoie et al.
31 indicate higher rates of depressive and
anxiety disorders among adult asthma patients. In our
study, we also detected higher rates of psychiatric disorders,
particularly depressive and anxiety disorders, in adult
asthma patients, which is similar to the findings of the
above-mentioned studies.
Using data from telephone interviews, McCauley et al.
17
reported that 125 children/adolescents (16.2%) met DSM-IV
criteria for one or more anxiety and depressive disorders
in the last 12 months, out of a sample of 767 young people
aged 11 to 17 years with a documented diagnosis of
and active treatment for asthma. In another study per-
formed in asthma patients, Goodwin et al.
32 reported that
approximately one in four (25.7%) pediatric asthma patients
in an inner city asthma clinic met criteria for a probable
diagnosis of a current anxiety disorder or depression (past
4-week prevalence).
IBS was consistently associated with mood and anxiety
disorders. Mikocka-Walus searched for the association
between IBS and psychiatric disorders. In their cross-
sectional survey of 32 consecutive outpatients with clinically
diagnosed IBS, 50% of the participants were anxious and
12% were depressed.
33 Gros et al. showed a high frequency
of IBS symptoms in patients with panic disorder, general-
ized anxiety disorder, and major depressive disorder
(n=357). The rates of symptoms consistent with a diagnosis
of comorbid IBS were found to vary based upon the
principal diagnosis, with generalized anxiety disorder
(25.8%), panic disorder (21.7%), and major depressive
disorder (25%) demonstrating a higher frequency of
comorbid IBS symptoms.
34 Ladep et al.
35 reported that 75
(56.8%) of 132 IBS patients were depressed, whereas only 54
(20.1%) of 268 non-IBS patients were depressed (n=418). IBS
patients were more likely to be depressed (odds ratio =5.21,
p=0.001).
Although these are cross-sectional data limiting causal
interpretation, prior studies have shown that anxiety and
depressive disorders in patients with chronic illness (such as
asthma and diabetes) are associated with a higher number
of physical symptoms and greater functional impair-
ment
17,36 even after controlling for severity of the relevant
medical diseases.
Limitations of this study
One of the limitations of this study was the sample size.
We used strict inclusion and exclusion criteria to exclude
the effects of drugs, systemic disease and comorbid
conditions to focus specifically on asthma. To prevent bias
and side effects of medication, we excluded asthma patients
who had been hospitalized or discharged from the hospital
in the last year. For this reason, the number of patients was
limited. We tried to take all suitable consecutive patients
and controls to prevent bias.
CONCLUSIONS
We found that the frequencies of IBS and psychiatric
disorders were higher in asthma patients than in members
of the control group. Psychiatric disorders were more
common in asthma patients with IBS than in those without
Table 7 - The frequency of psychiatric disorders in Group 1
and Group 2.
Psychiatric
disorders Group 1(n=35)
Group 2
(n=62) x
2 p
21 (60%) 31 (50%) 0.90 0.34
Group 1: Asthma patients with IBS.
Group 2: Asthma patients without IBS.
IBS: irritable bowel syndrome.
Table 8 - The distribution of IBS comorbidity and psychiatric disorders according to the severity of the asthma.
Mild persistent asthma Moderate persistent asthma x
2 p
Psychiatric disorders n=60 n=30 6.79 0.07
34 (56.7%) 12 (40%)
IBS comorbidity n=63 n=31 5.31 0.15
19 (30.2%) 15 (48.4%)
IBS: Irritable bowel syndrome.
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asthma patients with IBS and psychiatric disorders, FEV1
values were significantly lower than in asthma patients
without these disorders. Our findings suggest that it is
important for clinicians to accurately recognize that these
comorbid conditions are associated with additional func-
tional impairment.
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